AstraZeneca PLC (AZNL.XC)
Cboe UK - Cboe UK Real-time price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:29PM BST
| Previous close | 12,346.00 |
| Open | 12,356.00 |
| Bid | 12,396.00 x 0 |
| Ask | 12,396.00 x 0 |
| Day's range | 12,326.00 - 12,454.00 |
| 52-week range | 9,461.00 - 12,704.00 |
| Volume | |
| Avg. volume | 320,718 |
| Market cap | 192.139B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 3,861.06 |
| EPS (TTM) | 3.21 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 2.28 (1.85%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
ZacksWhy Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ZacksPharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
FDA rejects Merck (MRK) and AbbVie's (ABBV) filings for pipeline candidates. AstraZeneca (AZN) and Novo Nordisk (NVO) announce study failures.
ZacksAstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Data from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy before and after bladder removal surgery improves survival in patients.
© 2024 Yahoo. All rights reserved.